Soon-Shiong Patrick
- SEC CIK
- 0001189020
No open-market purchases or sales filed in the past year.
Current role at each company
- IBRX ImmunityBio, Inc.See remarksas of Apr 2, 2026
- PBLA Panbela Therapeutics, Inc.10% Owneras of Nov 19, 2024
- HLGN Heliogen, Inc.10% Owneras of Feb 20, 2024
- NHIQ NantHealth, Inc.Chief Executive Officeras of Aug 30, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Soon-Shiong Patrick as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PBLA Panbela Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2024 (view filing)6:40 PM ET | Nov 15 | 4 days | Soon-Shiong Patrick and 1 other10% Owner | PPurchase | +24.7M | – | – | – | DerivativePrice outlier |
HLGN Heliogen, Inc.
10% Owner11 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2024 (view filing)4:51 PM ET | Feb 15 | 5 days | Soon-Shiong Patrick and 3 others10% Owner | PPurchase | +442.3K | $1.52 | +$672.1K | New position442.3K after | |
| Sep 6, 2023 (view filing)9:12 PM ET | Sep 1 | 5 days | Soon-Shiong Patrick and 2 others10% Owner | PPurchase | +7.36K | $6.49 | +$47.8K | +0.8%946.3K after | |
| Jun 26, 2023 (view filing)9:51 PM ET | Jun 22 | 4 days | Soon-Shiong Patrick and 2 others10% Owner | PPurchase | +634.3K | $0.2303 | +$146.1K | +2.0%32.9M after | |
| Jun 21, 2023 (view filing)6:16 PM ET | Jun 16-21 | 5 days | Soon-Shiong Patrick and 2 others10% Owner | PPurchase | +366.7K | $0.2329 | +$85.4K | +1.2%32.2M after | 3 lots |
| Jun 15, 2023 (view filing)7:31 PM ET | Jun 13-15 | 2 days | Soon-Shiong Patrick and 2 others10% Owner | PPurchase | +1.73M | $0.2032 | +$350.6K | +5.7%31.9M after | 3 lots |
| Jun 9, 2023 (view filing)7:45 PM ET | Jun 7-9 | 2 days | Soon-Shiong Patrick and 2 others10% Owner | PPurchase | +3.74M | $0.2282 | +$852.2K | +14.1%30.1M after | 3 lots |
| Jun 5, 2023 (view filing)7:21 PM ET | Jun 1-2 | 4 days | Soon-Shiong Patrick and 2 others10% Owner | PPurchase | +180.0K | $0.2453 | +$44.2K | +0.7%26.4M after | 2 lots |
| Apr 17, 2023 (view filing)5:18 PM ET | Apr 13 | 4 days | Soon-Shiong Patrick and 2 others10% Owner | PPurchase | +7.08K | $0.25 | +$1.77K | 0.0%26.2M after | |
| Apr 12, 2023 (view filing)8:06 PM ET | Apr 10-12 | 2 days | Soon-Shiong Patrick and 2 others10% Owner | PPurchase | +540.6K | $0.2498 | +$135.0K | +2.1%26.2M after | 3 lots |
| Apr 10, 2023 (view filing)9:21 PM ET | Apr 5-6 | 5 daysLate | Soon-Shiong Patrick and 2 others10% Owner | PPurchase | +1.03M | $0.2468 | +$253.3K | +4.2%25.7M after | 2 lots |
IBRX ImmunityBio, Inc.
See remarks4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2023 (view filing)9:07 PM ET | Sep 11 | 2 days | Soon-Shiong Patrick and 4 othersSee remarks | PPurchaseConvertible Promissory Note | – | – | – | – | DerivativePrice outlier |
| May 16, 2023 (view filing) | May 12 | 4 days | Soon-Shiong PatrickSee remarks | PPurchaseConvertible Promissory Note | – | – | – | – | DerivativePrice outlier |
| Nov 8, 2022 (view filing)4:01 PM ET | Aug 31 | 69 daysLate | Soon-Shiong PatrickSee remarks | PPurchaseAmended and Restated Convertible Promissory Note | – | – | – | – | Derivative2 lotsPrice outlier |
| Nov 8, 2022 (view filing)4:01 PM ET | Aug 31 | 69 daysLate | Soon-Shiong PatrickSee remarks | PPurchaseSecond Amended and Restated Convertible Promissory Note | – | – | – | – | Derivative4 lotsPrice outlier |
NHIQ NantHealth, Inc.
Chief Executive Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 30, 2023 (view filing)5:26 PM ET | Aug 28 | 2 days | Soon-Shiong Patrick and 3 othersChief Executive Officer | PPurchase | +15.9M | $1.00 | +$16.0M | New position15.9M after | 2 lots |